These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35889769)

  • 1. Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia.
    Protic O; Di Pillo R; Montesanto A; Galeazzi R; Matacchione G; Giuliani A; Sabbatinelli J; Gurău F; Silvestrini A; Olivieri F; Antonicelli R; Bonfigli AR
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel nutraceutical combination (BruMeChol™) in subjects with mild hypercholesterolemia: study protocol of a randomized, double-blind, controlled trial.
    Bonfigli AR; Protic O; Olivieri F; Montesanto A; Malatesta G; Di Pillo R; Antonicelli R
    Trials; 2020 Jul; 21(1):616. PubMed ID: 32631422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a Novel Nutraceutical Combination (Aquilea Colesterol
    Domenech M; Casas R; Ruiz-León AM; Sobrino J; Ros E; Estruch R
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
    Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
    Nutr J; 2019 Feb; 18(1):13. PubMed ID: 30795775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
    Magno S; Ceccarini G; Pelosini C; Jaccheri R; Vitti J; Fierabracci P; Salvetti G; Airoldi G; Minale M; Saponati G; Santini F
    Lipids Health Dis; 2018 May; 17(1):124. PubMed ID: 29793488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk.
    Mazza A; Schiavon L; Rigatelli G; Torin G; Montanaro F; Lenti S
    Food Funct; 2018 Jul; 9(7):3845-3852. PubMed ID: 29951651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO
    Cicero AFG; D'Addato S; Borghi C
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of monacolin K-containing nutraceutical on cholesterol homeostasis re-establishment and CVD risk reduction in hypercholesterolemic subjects.
    Gojkovic T; Vladimirov S; Kotur-Stevuljevic J; Bogavac-Stanojevic N; Zeljkovic A; Vekic J; Antonic T; Spasojevic-Kalimanovska V
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5261-5267. PubMed ID: 34486702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A softgel dietary supplement containing esterified plant sterols and stanols improves the blood lipid profile of adults with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled replication study.
    McKenney JM; Jenks BH; Shneyvas E; Brooks JR; Shenoy SF; Cook CM; Maki KC
    J Acad Nutr Diet; 2014 Feb; 114(2):244-249. PubMed ID: 24287284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial.
    Derosa G; D'Angelo A; Romano D; Maffioli P
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28178209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
    Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
    Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
    Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
    J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of Dietetic Supplementation of a New Nutraceutical on Lipid Profile and Serum Inflammation Biomarkers in Hypercholesterolemic Patients.
    Riccioni G; Gammone MA; Currenti W; D'Orazio N
    Molecules; 2018 May; 23(5):. PubMed ID: 29757945
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial.
    Cicero AF; Colletti A; Fogacci F; Bove M; Rosticci M; Borghi C
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):13-18. PubMed ID: 27339779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Combination of
    Guerrero-Bonmatty R; Gil-Fernández G; Rodríguez-Velasco FJ; Espadaler-Mazo J
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention.
    Heinz T; Schuchardt JP; Möller K; Hadji P; Hahn A
    Nutr Res; 2016 Oct; 36(10):1162-1170. PubMed ID: 27865358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
    Galletti F; Fazio V; Gentile M; Schillaci G; Pucci G; Battista F; Mercurio V; Bosso G; Bonaduce D; Brambilla N; Vitalini C; D'Amato M; Giacovelli G
    Lipids Health Dis; 2019 Mar; 18(1):66. PubMed ID: 30885221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (
    Cicolari S; Pavanello C; Olmastroni E; Puppo MD; Bertolotti M; Mombelli G; Catapano AL; Calabresi L; Magni P
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.
    Kerzner B; Corbelli J; Sharp S; Lipka LJ; Melani L; LeBeaut A; Suresh R; Mukhopadhyay P; Veltri EP;
    Am J Cardiol; 2003 Feb; 91(4):418-24. PubMed ID: 12586255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of a combined lipid-lowering nutraceutical on cholesterolemia, hs-CRP level and endothelial function in moderately hypercholesterolemic subjects.
    Cicero AF; Colletti A; Rosticci M; Grandi E; Borghi C
    J Biol Regul Homeost Agents; 2016; 30(2):593-8. PubMed ID: 27358154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.